NL6701919A - - Google Patents

Info

Publication number
NL6701919A
NL6701919A NL6701919A NL6701919A NL6701919A NL 6701919 A NL6701919 A NL 6701919A NL 6701919 A NL6701919 A NL 6701919A NL 6701919 A NL6701919 A NL 6701919A NL 6701919 A NL6701919 A NL 6701919A
Authority
NL
Netherlands
Application number
NL6701919A
Other versions
NL151630B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6701919A publication Critical patent/NL6701919A/xx
Publication of NL151630B publication Critical patent/NL151630B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/913Aspergillus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/939Rhizopus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NL676701919A 1966-02-09 1967-02-08 Werkwijze ter bereiding van een farmaceutisch preparaat met anti-inflammatoire werking. NL151630B (nl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB571966 1966-02-09
GB56249/66A GB1158492A (en) 1966-02-09 1966-02-09 Improvements in Acylated Steroids
GB3001868 1966-02-09

Publications (2)

Publication Number Publication Date
NL6701919A true NL6701919A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1967-08-10
NL151630B NL151630B (nl) 1976-12-15

Family

ID=27254686

Family Applications (1)

Application Number Title Priority Date Filing Date
NL676701919A NL151630B (nl) 1966-02-09 1967-02-08 Werkwijze ter bereiding van een farmaceutisch preparaat met anti-inflammatoire werking.

Country Status (8)

Country Link
US (1) US3506694A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH487134A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK117896B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (2) FR1513708A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (2) GB1158492A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL151630B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO127577B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE342239B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856956A (en) * 1967-02-02 1974-12-24 Boots Pure Drug Co Ltd 17-acyloxysteroids and their manufacture
FR2559156B1 (fr) * 1984-02-03 1989-03-24 Roussel Uclaf Procede de preparation de derives de la prednisone et produits intermediaires de ce procede
JP2655190B2 (ja) * 1989-06-21 1997-09-17 エスエス製薬 株式会社 コルチコステロイド含有軟膏剤
HK1056180B (en) 2000-08-05 2008-07-25 Glaxo Group Limited 6.alpha.,9.alpha.-difluoro-17.alpha.-(2-furanylcarboxyl)oxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
ATE411334T1 (de) * 2001-04-30 2008-10-15 Glaxo Group Ltd Antiphlogistische 7.beta.-carbothioate esterderivate von androstan mit einer 17.alpha.- zyklischen estergruppe
ES2307751T3 (es) * 2001-06-12 2008-12-01 Glaxo Group Limited Nuevos esteres heterociclicos centi-inflamatorios 17 alfa de derivados 17 beta de carbotioato de androstano.
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
WO2005021515A2 (en) * 2003-08-29 2005-03-10 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
WO2005051931A2 (en) * 2003-11-26 2005-06-09 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
US20080009535A1 (en) * 2004-08-30 2008-01-10 Sarala Balachandran Inhibitors of phosphodiesterase type-IV
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
US7915286B2 (en) 2005-09-16 2011-03-29 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
EP1948167A1 (en) * 2005-10-19 2008-07-30 Ranbaxy Laboratories, Ltd. Compositions of phosphodiesterase type iv inhibitors
RU2008119323A (ru) 2005-10-19 2009-11-27 Рэнбакси Лабораториз Лимитед (In) Фармацевтические композиции мускаринового рецептора
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
KR20090069309A (ko) * 2006-09-22 2009-06-30 랜박시 래보러터리스 리미티드 포스포디에스터라제 타입-ⅳ의 저해제
WO2008035316A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
EP1958947A1 (en) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
PT2124944E (pt) * 2007-03-14 2012-05-17 Ranbaxy Lab Ltd Derivados de pirazolo[3,4-b]piridina como inibidores de fosfodiesterase
EP2124943A1 (en) * 2007-03-14 2009-12-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b]pyridine derivatives as phosphodiesterase inhibitors
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
CN102372762B (zh) * 2010-08-18 2012-11-07 天津金耀集团有限公司 一种孕甾11位β羟基合成的工艺
CN107556357A (zh) * 2017-09-28 2018-01-09 湖南科瑞生物制药股份有限公司 丙酸地泼罗酮的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2923721A (en) * 1955-12-13 1960-02-02 Lab Francais Chimiotherapie Method of preparing 3-keto delta1, 4 steroids
US2902410A (en) * 1957-09-26 1959-09-01 Upjohn Co Process for the 1,2-dehydrogenation of a steroid with septomyxa

Also Published As

Publication number Publication date
GB1158492A (en) 1969-07-16
NO127577B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-07-16
CH487134A (fr) 1970-03-15
NL151630B (nl) 1976-12-15
DE1618095B2 (de) 1975-09-18
DK117896B (da) 1970-06-15
US3506694A (en) 1970-04-14
DE1618095A1 (de) 1971-03-25
FR6137M (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1968-06-24
GB1159490A (en) 1969-07-23
SE342239B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-01-31
FR1513708A (fr) 1968-02-16

Similar Documents

Publication Publication Date Title
FR6137M (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT281852B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1141566A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1534566A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU218666A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1144366A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1111066A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU6703465A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1393566A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE674987A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE666282A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE693506A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE693137A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE693069A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE693011A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE693005A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE692997A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE692402A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE692043A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE675173A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE675139A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE675084A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE693925A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE674882A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE674792A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Legal Events

Date Code Title Description
TNT Modifications of names of proprietors of patents or applicants of examined patent applications

Owner name: THE BOOTS COMPANY PLC.

V1 Lapsed because of non-payment of the annual fee
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: BOOTS PURE